FHAM
COLL icon

Folger Hill Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Folger Hill Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-140,000
Closed -$2.58M – 243
2017
Q4 		$2.58M Buy
+140,000
New +$2.01M 0.26% 109

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Folger Hill Asset Management's COLL Position: Q1 2018 in Review

Folger Hill Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2018, closing a stake of 140,000 shares — an estimated $2.58M sold.

Folger Hill Asset Management first reported a position in COLL in Q4 2017 and held it in 1 quarter. The position peaked at $2.58M in Q4 2017. 140 funds tracked by Wall St. Rank hold COLL as of Q1 2018.

  • Folger Hill Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2018 after selling out during the quarter.
  • Folger Hill Asset Management sold 140,000 Collegium Pharmaceutical shares in Q1 2018, an estimated $2.58M.
  • Folger Hill Asset Management first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 1 quarter.
  • Folger Hill Asset Management's Collegium Pharmaceutical position peaked at $2.58M in Q4 2017.
  • 140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2018.

Based on Folger Hill Asset Management's 13F filing for Q1 2018, filed 15 May 2018.